PRESCRIBING · PART D · 2024
Total Rx claims
568
Beneficiaries
—
Total drug cost
$178K
Distinct drugs
17
Brand share
65.3%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter73 claims
Albuterol Sulfate64 claims
Montelukast Sodium62 claims
Azithromycin54 claims
Fluticasone Propion/Salmeterol44 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE